DNA RNA and Cells

20 Mar 2009 Another LNA-based RNA Inhibitor Enters Clinical Trials
19 Mar 2009 Enzon Reveals New LNA Targets
17 Mar 2009 Opexa's Stem Cell Therapy for Diabetes Shows Progress
16 Mar 2009 Healthpoint Initiates Phase II, DoseFinding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
09 Mar 2009 Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
09 Mar 2009 FDA Appeal Decision Indicates that Genasense® Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Trial
06 Mar 2009 Cytori Stem & Regenerative Cell Heart Attack Trial Feasible & Safe
06 Mar 2009 OPKO Health Announces Update on Phase III Clinical Trial of Bevasiranib
05 Mar 2009 Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars
03 Mar 2009 FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
02 Mar 2009 TissueGene Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee
02 Mar 2009 Pluristem Therapeutics Receives FDA Clearance to Begin "First-In-Human" Placenta-Derived Stem Cell Clinical Trial
25 Feb 2009 First Group of Heart Failure Patients Treates With "Off-The-Shelf" Adult stem Cells Successfully Pas
23 Feb 2009 MDRNA Successfully Silences Gene Targets in Animal Models Using Novel UsiRNA Constructs
20 Feb 2009 Neuralstem's ALS Trial on Clinical Hold
19 Feb 2009 AVI BioPharma Announces Treatment of First Patient in Systemic Clinical Trial of AVI-4658 for Treatment of Duchenne Muscular Dystrophy
13 Feb 2009 MDRNA, Inc. Announces Licensing Agreement With Roche
12 Feb 2009 Alnylam and Collaborators Present Data from Multiple Pre-Clinical and Clinical Programs at RNAi Keystone Symposium
12 Feb 2009 Antisense Therapeutics Projects Update
12 Feb 2009 Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
12 Feb 2009 Results of First Interim Efficacy Analysis for Riquent Phase 3 ASPEN Trial: Continuation of the Trial is Futile
12 Feb 2009 Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer
11 Feb 2009 Alnylam and Collaborators Publish New Pre-Clinical Research Demonstrating In Vivo Efficacy of Systemically Delivered RNAi Therapeutics in Ovarian Cancer
11 Feb 2009 Regenocyte Therapeutic Reports Successful Treatment of Cardiomyopathy with Stem Cell
05 Feb 2009 Isis Initiates Phase 1 Clinical Trial of SGLT2 Antisense Drug

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up